Wortmann, S.B.* ; Zietkiewicz, S.* ; Guerrero-Castillo, S.* ; Feichtinger, R.G.* ; Wagner, M. ; Russell, J.* ; Ellaway, C.* ; Mróz, D.* ; Wyszkowski, H.* ; Weis, D.* ; Hannibal, I.* ; von Stülpnagel, C.* ; Cabrera-Orefice, A.* ; Lichter-Konecki, U.* ; Gaesser, J.* ; Windreich, R.* ; Myers, K.C.* ; Lorsbach, R.* ; Dale, R.C.* ; Gersting, S.* ; Prada, C.E.* ; Christodoulou, J.* ; Wolf, N.I.* ; Venselaar, H.* ; Mayr, J.A.* ; Wevers, R.A.*
Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency.
Genet. Med. 23, 1705-1714 (2021)
PURPOSE: To investigate monoallelic CLPB variants. Pathogenic variants in many genes cause congenital neutropenia. While most patients exhibit isolated hematological involvement, biallelic CLPB variants underlie a neurological phenotype ranging from nonprogressive intellectual disability to prenatal encephalopathy with progressive brain atrophy, movement disorder, cataracts, 3-methylglutaconic aciduria, and neutropenia. CLPB was recently shown to be a mitochondrial refoldase; however, the exact function remains elusive. METHODS: We investigated six unrelated probands from four countries in three continents, with neutropenia and a phenotype dominated by epilepsy, developmental issues, and 3-methylglutaconic aciduria with next-generation sequencing. RESULTS: In each individual, we identified one of four different de novo monoallelic missense variants in CLPB. We show that these variants disturb refoldase and to a lesser extent ATPase activity of CLPB in a dominant-negative manner. Complexome profiling in fibroblasts showed CLPB at very high molecular mass comigrating with the prohibitins. In control fibroblasts, HAX1 migrated predominantly as monomer while in patient samples multiple HAX1 peaks were observed at higher molecular masses comigrating with CLPB thus suggesting a longer-lasting interaction between CLPB and HAX1. CONCLUSION: Both biallelic as well as specific monoallelic CLPB variants result in a phenotypic spectrum centered around neurodevelopmental delay, seizures, and neutropenia presumably mediated via HAX1.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Protein; Mutations; Substrate; Domain; Hsp104
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
1530-0366
e-ISSN
1098-3600
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 23,
Issue: 9,
Pages: 1705-1714
Article Number: ,
Supplement: ,
Series
Publisher
Lippincott Williams & Wilkins
Publishing Place
Baltimore, Md.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
Grants
New South Wales Office of Health and Medical Research Sydney Genomics Collaborative grant
Victorian Government's Operational Infrastructure Support Program
Royal Children's Hospital Foundation
Copyright
Erfassungsdatum
2021-07-16